OCE ‘Project’ To Help Understand Trial Site Selection, Also May Inform Policy

Project Site Selector will allow FDA Oncology Center of Excellence staff to discuss site selection process with industry and potentially help improve clinical trial diversity efforts.

Trial site selection is the subject of the next Oncology Center of Excellence “project” and could be a precursor to a more formal effort by the US Food and Drug Administration to improve clinical research diversity.

Project Site Selector will include discussions with industry about how trial sites are picked. OCE Director Richard Pazdur said the...